Rheumatoid Arthritis Clinical Trials in St Louis, Missouri

4 studies are recruiting for rheumatoid arthritis in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

    This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Research Site, St Louis, Missouri
    Locations
    35 in total
    Run by
    AstraZeneca

    See if you can join NCT07201558 on ClinicalTrials.gov

  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    52 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03816345 on ClinicalTrials.gov

  3. A Study of AZD0120 in Autoimmune Diseases

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arth…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Research Site, St Louis, Missouri
    Locations
    22 in total
    Run by
    AstraZeneca

    See if you can join NCT07295847 on ClinicalTrials.gov

  4. A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

    Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Research Site, St Louis, Missouri
    Locations
    144 in total
    Run by
    AstraZeneca

    See if you can join NCT07276581 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.